MedTrace Logo

Finding and Treating Unsuspected and Resistant TB to Reduce Hospital Transmission

NCT02355223 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11060

Last updated 2018-01-12

No results posted yet for this study

Summary

The study is designed to evaluate the clinical impact of a novel strategy for tuberculosis (TB) infection control known as FAST (Find cases Actively based on cough surveillance, Separate temporarily, and Treat effectively). It is anticipated that this will decrease time to effective treatment initiation and also decrease transmission of TB to health care workers.

Conditions

Interventions

OTHER

FAST

See information in arm description

Sponsors & Collaborators

  • Hospital Nacional Hipólito Unanue

    collaborator UNKNOWN

  • Socios En Salud Sucursal, Peru

    collaborator OTHER

  • Hospital Nacional Arzobispo Loayza

    collaborator OTHER

  • Hospital Nacional Sergio Bernales

    collaborator UNKNOWN

  • Brigham and Women's Hospital

    lead OTHER

Principal Investigators

  • Edward Nardell, MD · Brigham and Women's Hospital

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2020-02-29
Completion
2020-02-29

Countries

  • Peru

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02355223 on ClinicalTrials.gov